Does DOXORUBICIN Cause Malignant neoplasm progression? 2,193 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,193 reports of Malignant neoplasm progression have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 2.7% of all adverse event reports for DOXORUBICIN.
2,193
Reports of Malignant neoplasm progression with DOXORUBICIN
2.7%
of all DOXORUBICIN reports
605
Deaths
342
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DOXORUBICIN?
Of the 2,193 reports, 605 (27.6%) resulted in death, 342 (15.6%) required hospitalization, and 119 (5.4%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 2,193 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Product use in unapproved indication (3,502)
Nausea (2,925)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DOXORUBICIN Alternatives Have Lower Malignant neoplasm progression Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE